Skip to main content
Banswara Syntex Ltd. logo

Banswara Syntex Ltd. — Investor Relations & Filings

Ticker · BANSWRAS ISIN · INE629D01020 LEI · 335800P7QV3XFCEREI20 BSE.NS Manufacturing
Filings indexed 1,209 across all filing types
Latest filing 2024-10-30 Earnings Release
Country IN India
Listing BSE.NS BANSWRAS

About Banswara Syntex Ltd.

https://www.banswarasyntex.com/

Banswara Syntex Ltd. is a vertically integrated manufacturer specializing in the production of yarn, fabric, and readymade garments. The company manages the complete textile value chain, encompassing spinning, weaving, processing, and garmenting. Its product range includes synthetic blended yarns, wool-blended yarns, and specialized fabrics for suiting, shirting, and technical applications. The garment division focuses on high-quality formal wear, including trousers, jackets, and waistcoats. Known for its expertise in stretch fabrics and performance textiles, the company provides customized solutions to global fashion brands and retailers. Operations are characterized by a focus on technical innovation and sustainable production practices across its manufacturing facilities.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Earnings Release Classification · 90% confidence The document is an official communication from Banswara Syntex Limited notifying about a scheduled earnings conference call to discuss operational and financial performance for Q2 & H1 FY25. It includes details such as date, time, access numbers, and participants. The document does not contain actual financial data or results but is an announcement of the upcoming earnings call event. According to the classification rules, such a document is best classified as a Call Transcript (CT) category if it contained the full transcript, but since this is only an announcement of the call, it fits the category of an Earnings Release (ER) announcement or a Call Transcript (CT) invitation. However, the document specifically announces the schedule of the earnings conference call, not the earnings results themselves. The closest and most appropriate category is Call Transcript (CT) as it relates to the earnings call event, but since it is only an invitation and not the transcript, the best fit is Earnings Release (ER) as it is the initial announcement related to earnings. Confidence is high due to clear mention of earnings call and financial period. H1 2025
2024-10-30 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2024-10-29 English
BANSWARA SYNTEX LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2024 ,inter alia, to consider and approve Un-Audited Standalone and ....
Regulatory Filings Classification · 95% confidence The document is a formal notice from the company to stock exchanges about an upcoming Board of Directors meeting scheduled for November 5, 2024. The agenda includes consideration and approval of unaudited standalone and consolidated financial results for the quarter/half year ended September 30, 2024, along with the limited review report of the auditor. The document also mentions the opening of the trading window post declaration of these results. The document is short (1860 characters) and serves as an intimation or announcement of a board meeting and upcoming financial results, not the financial results report itself. It does not contain actual financial data or detailed financial statements. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about the board meeting and financial results declaration schedule, not the report itself or a detailed management discussion.
2024-10-29 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notice from the company to stock exchanges about an upcoming Board of Directors meeting scheduled for November 5, 2024. The agenda includes consideration and approval of unaudited standalone and consolidated financial results for the quarter/half year ended September 30, 2024, along with the limited review report of the auditor. The document also mentions the opening of the trading window post declaration of these results. The document is short (1860 characters) and serves as an intimation or announcement of a board meeting and upcoming financial results, not the financial results report itself. It does not contain actual financial data or detailed financial statements. Therefore, it is best classified as a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit other specific categories like Interim Report or Earnings Release, which require substantive financial data or key highlights respectively.
2024-10-29 English
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 as received from RTA
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th September 2024. It is a compliance certificate related to dematerialization of securities and their processing by the Registrar and Transfer Agent. The document is short (2664 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is not an announcement of a report but the certificate itself. Therefore, it fits best under Regulatory Filings (RNS), which covers compliance documents and certifications that do not fit other categories.
2024-10-08 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th September 2024. It confirms compliance related to dematerialization of securities and related processes. The document is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion but is a formal attestation of regulatory compliance. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents and certifications that do not fit other specific categories.
2024-10-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.